NZCR leading the world in gene editing research

Earlier this month, at NZCR in Auckland, a New Zealander was the first person in the world to be injected with gene-editing instructions to try and modify a single part of their DNA to stop it producing bad cholesterol. Past laboratory results, resulted in a 70 percent reduction in cholesterol levels.

Dr. Andrew Bellinger is the chief scientific and medical officer of Verve Therapeutics and he joined Mike Hosking to discuss this this.

https://www.iheart.com/podcast/211-the-mike-hosking-breakfast-24837692/episode/dr-andrew-bellinger-verve-therapeutics-on-gene-99773864/

#NZCR advancing global health

Get in touch today

About NZCR

Auckland

Christchurch

Hamilton

Wellington